CN Patent

CN113784954A — 多晶型化合物和其用途

Assigned to Aldeyra Therapeutics Inc · Expires 2021-12-10 · 4y expired

What this patent protects

本发明涉及充当毒性醛的清除剂的小分子治疗剂的游离碱和盐形式以及其组合物。本发明进一步涉及所述游离碱和盐形式以及其组合物用于治疗其中疾病、病症或病状的发病机制涉及醛毒性的所述疾病、病症或病状的用途。

USPTO Abstract

本发明涉及充当毒性醛的清除剂的小分子治疗剂的游离碱和盐形式以及其组合物。本发明进一步涉及所述游离碱和盐形式以及其组合物用于治疗其中疾病、病症或病状的发病机制涉及醛毒性的所述疾病、病症或病状的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN113784954A
Jurisdiction
CN
Classification
—
Expires
2021-12-10
Drug substance claim
No
Drug product claim
No
Assignee
Aldeyra Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.